Sort
15,842 grants matching “pancreatic cancer”
Core 2: Animal Model and Experimental Therapeutics Core [AMETC]
$248,086Maneesh Jain · University Of Nebraska Medical Center · P01 · FY2022 · CA
Integrated Genomewide Analysis of the lpL1 Kinase Signaling Network
$248,085Tony Hazbun · Purdue University · R01 · FY2010 · GM
Preclinical Models for Cancer Therapeutic Development
$248,045Youngkyu Park · Cold Spring Harbor Laboratory · R50 · FY2021 · CA
Preclinical Models for Cancer Therapeutic Development
$248,045Youngkyu Park · Cold Spring Harbor Laboratory · R50 · FY2025 · CA
Preclinical Models for Cancer Therapeutic Development
$248,045Youngkyu Park · Cold Spring Harbor Laboratory · R50 · FY2022 · CA
Preclinical Models for Cancer Therapeutic Development
$248,045Youngkyu Park · Cold Spring Harbor Laboratory · R50 · FY2023 · CA
Preclinical Models for Cancer Therapeutic Development
$248,045Youngkyu Park · Cold Spring Harbor Laboratory · R50 · FY2024 · CA
Fresno State-SBCC Partnership: Cancer Research & Training for Central PA (1 of 2)
$248,044Lynnette Zelezny · California State University Fresno · P20 · FY2011 · CA
Molecular Mechanisms Controlling Endocytic Recycling
$248,015Steven H Caplan · University Of Nebraska Medical Center · R01 · FY2007 · GM
JAK1 Signaling in Pancreatic Cancer Initiation and Progression
$248,005Kay-Uwe Wagner · Wayne State University · R01 · FY2018 · CA
Proteasome Inhibition and ER Stress
$247,971David J McConkey · University Of Tx Md Anderson Can Ctr · R01 · FY2012 · CA
KLF4 Genetic and Epigenetic Changes in Human Pancreatic Cancer
$247,971Keping Xie · University Of Tx Md Anderson Can Ctr · R01 · FY2012 · CA
Proteasome Inhibition and ER Stress
$247,971David J McConkey · University Of Tx Md Anderson Can Ctr · R01 · FY2011 · CA
KLF4 Genetic and Epigenetic Changes in Human Pancreatic Cancer
$247,971Keping Xie · University Of Tx Md Anderson Can Ctr · R01 · FY2011 · CA
Regulation of Food Intake & Body Adiposity by Peptide YY
$247,958Roger Reidelberger · Creighton University · R01 · FY2006 · DK
Molecular Mechanisms of Growth Factor Modulated Proliferation
$247,942William Farrar · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Hepatic metabolic reprogramming drives pancreatic cancer cachexia
$247,925Aaron Grossberg · Oregon Health & Science University · K08 · FY2023 · CA
Hepatic metabolic reprogramming drives pancreatic cancer cachexia
$247,925Aaron Grossberg · Oregon Health & Science University · K08 · FY2020 · CA
Hepatic metabolic reprogramming drives pancreatic cancer cachexia
$247,925Aaron Grossberg · Oregon Health & Science University · K08 · FY2021 · CA
Hepatic metabolic reprogramming drives pancreatic cancer cachexia
$247,925Aaron Grossberg · Oregon Health & Science University · K08 · FY2022 · CA
Targeting MARK2-HDAC signaling to overcome paclitaxel resistance in pancreatic cancer
$247,902Jixin Dong · University Of Oklahoma Hlth Sciences Ctr · U54 · FY2024 · CA
MUC1 in Therapy Resistance
$247,902Michael A Hollingsworth · University Of Oklahoma Hlth Sciences Ctr · U54 · FY2024 · CA
Tissue and Pathology Core
$247,839Massimo F Loda · Dana-Farber Cancer Inst · P50 · FY2016 · CA
Cost and Quality of Cancer Surgery
$247,796Vivian Ho · Rice University · R01 · FY2011 · CA
Acquisition of a CytoFLEX LX Flow Cytometer to characterize extracellular vesicle (EV) formation and multiparametric flow cytometry assays
$247,748Melinda K. Duncan · University Of Delaware · P20 · FY2023 · GM